Novartis Office of Grants & Education Request for Proposal (RFP) - Professional Medical Education
Supports accredited educational programs to advance rheumatologists’ knowledge of CAR-T therapy science, evidence, and clinical use in autoimmune rheumatic diseases.
Funder: Novartis
Due Dates: July 31, 2026 (Full application deadline)
Funding Amounts: Total pool: $225,000; multiple single- or multi-support initiatives may be funded.
Summary: Supports accredited, independent medical education programs to advance rheumatologists’ understanding of CAR-T therapy in autoimmune rheumatic diseases.
Key Information: Applications must be US-focused and submitted via Novartis Grants Central Station by 5 PM EST on July 31, 2026.
Description
This grant opportunity from the Novartis Office of Grants & Education seeks to fund innovative, accredited, and independent medical education programs that address the educational needs of rheumatologists regarding CAR-T therapy in autoimmune rheumatic diseases. The goal is to improve patient care by advancing evidence-based knowledge of the scientific rationale, clinical evidence, mechanisms of action, safety considerations, and evolving role of CAR-T and cellular therapies for refractory autoimmune rheumatic diseases. Funded activities should be non-promotional and may include enduring online modules, case-based expert series, microlearning, podcasts, downloadable resources, and robust outcome measurement tools. Programs must comply with relevant laws, regulations, and industry standards.
